Solving age-old problems using novel biomaterials

Advamedica has developed a “Protonated Bio adhesive Technology” under the name of Axiostat, which is a bioactive hemostatic dressing. It works on a unique charge-based mechanism of mucoadhesion which forms a mechanical barrier on the bleeding site.

Advamedica's Advanced Wound Care line includes the next-generation MaxioCel wound dressing, which is based on Bioactive Microfiber Gelling Technology (BMG). Maxiocel is intended to manage moderately to heavily exuding chronic and acute wounds and to provide a barrier against bacterial penetration. The Maxiocel Chitosan Wound Dressing can be used in the control of minor bleeding.

Strong Bioadhesion - Icon

Strong Bioadhesion

Hemostat Patch with Sealant Features

Ease of Removal - Icon

Ease of Removal

The Axiostat Patch is a sterile, single use, non-absorbable hemostatic dressing composed of Chitosan, a well-known natural polysaccharide which has widely recognized hemostatic properties. Axiostat’s structure allows it to rapidly absorb and lock blood plasma during its hemostasis action. Axiostat is available in 40+ countries across the globe

The Axiostat Gauze is a single-use, non-absorbable non-woven hemostatic gauze. It is made of non-woven fabric derived from chitosan, which is a natural polymer which is known for its mucoadhesive and hemostatic properties. When applied directly to a wound the dressing controls bleeding and can be removed after the clotting has occurred.


​ Ax-Surgi is the first FDA-cleared chitosan-based surgical hemostat intended for the temporary control of internal organ space bleeding in patients displaying class III or IV bleeding.

The Maxiocel Chitosan Wound Dressing is a soft, sterile, single-use absorbent gelling wound dressing used for absorption of wound exudate. The Maxiocel Chitosan Wound Dressing helps in maintaining a moist, optimal wound healing environment, helps in autolytic debridement, and is easy to remove. The Maxiocel Chitosan Wound Dressing can be kept on the wound site for up to 7 days.

Accomplished Medical Sales Professional with a 20 year record of growing markets, increasing product penetration and leading high performance sales teams in hemostat business. Previously Phil was Vice President at Core Scientific and spent a decade at ZMedica, a leading hemostat company as Regional Sales Director. Phil has a business management degree from Florida State University.

Dr S V Mahadevan

Dr. Mahadevan is a Professor of Emergency Medicine at Stanford University where he has been a recipient of numerous teaching awards. He also serves as the Director of Global Affairs and Strategy for Stanford Medicine. He received his medical degree from David Geffen School of Medicine at UCLA.

Dr Shiladitya Sengupta

Dr. Sengupta serves as the Associate Professor of Medicine at HMS and as the Associate Professor of Health Sciences and Technology at MIT. Dr. Sengupta received his PhD from University of Cambridge as a British Chevening and Nehru Scholar, and is a recipient of the TR35 Innovator Award from the MIT Technology Review Magazine and the Era of Hope Scholar Award from the US Department of Defense.

Satish Jajodia

Satish brings a wealth of diverse experiences to his CFO role at Advamedica. In addition to his Fortune 500 roles (FedEx, Citi, AmEx, JPM Chase) in various leadership capacities across multiple countries, he has worked with a number of startups and SMBs as their in-house or consulting CFO. Over the last three years, Satish has helped companies raise over $100 million in venture capital and financing.

Maria Samuel

Quality professional with over 25 years of experience in the medical device, pharmaceutical, and software industries.
Maria is specialized in developing and implementing Quality Management Systems and has deep knowledge and experience in audit preparation, resolution/remediation as per regulatory compliance in ISO 13485, 21 CFR Part 820, EU MDR, MDSAP, and other regional regulations (China, Taiwan, Brazil, Japan, Canada, Australia, Korea, Switzerland, etc.)

Samantha Labanti

Samantha is Director of Clinical Marketing at Advamedica. Previously she was Global Training Manager in Terumo Aortic overseeing all training and clinical skills. Prior to that Samantha was National Sales & Marketing Manager in Bolton Medical, Italy for almost a decade. Samantha has done Executive MBA in Strategic Marketing and has Degree in Professional nursing from the University of Bologna, Italy.

Edward Hallaran

Edward is US – National Sales Director at Advamedica. He comes with many decades of experience selling novel hemostats and woundcare products in over 26 states in the US. He was earlier Regional Sales Director at Z-Medica managing business of their Hemostatic product line for Surgery, Trauma, Cardiology, Burn and Wound Care. He is passionate about creating top performing teams, driven by diversity, inclusion, values and accountability. Edward has a Bachelor of Business Administration from Dowling College.

Oscar Rospigliosi

Oscar Rospigliosi is a Senior MedTech executive with broad experience in medical device sales and marketing. He was the CEO & Director at Scion Biomedical and prior to that, he was a CEO at Bolton Medical Group, guiding the company from $4.5mn in annual revenues to $80mn in the cardio-thoracic market.

Leo Mavely

Leo Mavely is the president of Advamedica Inc. He is passionate about medtech innovations for unmet healthcare needs, and has been featured by Fortune Magazine in 40 under 40 business leaders and by Entrepreneur Magazine in 35 under 35 Game-Changing Entrepreneurs. He holds a Bachelor’s degree in Bioengineering.


If you continue, you will leave this site and go to a non-US site.

Some of the products on the other site may not be approved in the United States.”


If you continue, you will leave this site and go to a non-US site.

Some of the products on the other site may not be approved in the United States.”